[Skip to Content]
[Skip to Content Landing]

Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease

Educational Objective
To understand that the excess risk of cardiovascular disease attributable to smoking can persist for many years after smoking cessation.
1 Credit CME
Key Points

Question  Among heavy smokers (ie, ≥20 pack-years), what is the association between time since smoking cessation and subsequent risk of cardiovascular disease?

Findings  In this observational cohort study of 8770 participants, former heavy smokers’ risk of cardiovascular disease was significantly lower within 5 years of smoking cessation relative to current smokers (hazard ratio, 0.61) but remained significantly elevated for at least 5 to 10 years and possibly for 25 years after cessation relative to never smokers.

Meaning  Compared with never smokers, former heavy smokers may have significantly elevated cardiovascular disease risk beyond 5 years after cessation.

Abstract

Importance  The time course of cardiovascular disease (CVD) risk after smoking cessation is unclear. Risk calculators consider former smokers to be at risk for only 5 years.

Objective  To evaluate the association between years since quitting smoking and incident CVD.

Design, Setting, and Participants  Retrospective analysis of prospectively collected data from Framingham Heart Study participants without baseline CVD (original cohort: attending their fourth examination in 1954-1958; offspring cohort: attending their first examination in 1971-1975) who were followed up through December 2015.

Exposures  Time-updated self-reported smoking status, years since quitting, and cumulative pack-years.

Main Outcomes and Measures  Incident CVD (myocardial infarction, stroke, heart failure, or cardiovascular death). Primary analyses included both cohorts (pooled) and were restricted to heavy ever smokers (≥20 pack-years).

Results  The study population included 8770 individuals (original cohort: n = 3805; offspring cohort: n = 4965) with a mean age of 42.2 (SD, 11.8) years and 45% male. There were 5308 ever smokers with a median 17.2 (interquartile range, 7-30) baseline pack-years, including 2371 heavy ever smokers (406 [17%] former and 1965 [83%] current). Over 26.4 median follow-up years, 2435 first CVD events occurred (original cohort: n = 1612 [n = 665 among heavy smokers]; offspring cohort: n = 823 [n = 430 among heavy smokers]). In the pooled cohort, compared with current smoking, quitting within 5 years was associated with significantly lower rates of incident CVD (incidence rates per 1000 person-years: current smoking, 11.56 [95% CI, 10.30-12.98]; quitting within 5 years, 6.94 [95% CI, 5.61-8.59]; difference, −4.51 [95% CI, −5.90 to −2.77]) and lower risk of incident CVD (hazard ratio, 0.61; 95% CI, 0.49-0.76). Compared with never smoking, quitting smoking ceased to be significantly associated with greater CVD risk between 10 and 15 years after cessation in the pooled cohort (incidence rates per 1000 person-years: never smoking, 5.09 [95% CI, 4.52-5.74]; quitting within 10 to <15 years, 6.31 [95% CI, 4.93-8.09]; difference, 1.27 [95% CI, −0.10 to 3.05]; hazard ratio, 1.25 [95% CI, 0.98-1.60]).

Conclusions and Relevance  Among heavy smokers, smoking cessation was associated with significantly lower risk of CVD within 5 years relative to current smokers. However, relative to never smokers, former smokers’ CVD risk remained significantly elevated beyond 5 years after smoking cessation.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Corresponding Author: Meredith S. Duncan, MA, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 2525 West End Ave, Ste 300-A, Nashville, TN 37203 (meredith.s.duncan@vumc.org).

Author Contributions: Ms Duncan and Dr Tindle had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Duncan, Freiberg, Greevy, Vasan, Tindle.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Duncan, Freiberg, Vasan, Tindle.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Duncan, Freiberg, Greevy, Kundu.

Obtained funding: Vasan, Tindle.

Administrative, technical, or material support: Vasan, Tindle.

Supervision: Freiberg, Greevy, Vasan, Tindle.

Conflict of Interest Disclosures: Dr Tindle reported providing input on design for a phase 3 trial of cytisine proposed by Achieve Life Sciences and being a principal investigator of National Institutes of Health–sponsored studies for smoking cessation that include medications donated by the manufacturers. No other disclosures were reported.

Funding/Support: Dr Freiberg is supported by the Dorothy and Laurence Grossman Chair in Cardiology. Dr Vasan is supported in part by the Evans Medical Foundation and the Jay and Louis Coffman Endowment from the Department of Medicine, Boston University School of Medicine. Dr Tindle is supported by the William Anderson Spickard Jr Chair in Medicine and the National Cancer Institute Moonshot Initiative (grant 3P30CA068485-22S3). The FHS received the support of contracts NO1-HC-25195, HHSN268201500001I, and 75N92019D00031 from the National Heart, Lung, and Blood Institute for this research.

Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.

Additional Contributions: We acknowledge the dedication of the FHS study participants and staff, without whom this research would not be possible.

References
1.
Dawber  TR.  Summary of recent literature regarding cigarette smoking and coronary heart disease.  Circulation. 1960;22:164-166.PubMedGoogle Scholar
2.
Doll  R, Hill  AB.  The mortality of doctors in relation to their smoking habits: a preliminary report.  Br Med J. 1954;1(4877):1451-1455. doi:10.1136/bmj.1.4877.1451PubMedGoogle ScholarCrossref
3.
Surgeon General’s Advisory Committee on Smoking and Health.  Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: US Government Printing Office; 1964.
4.
Doyle  JT, Dawber  TR, Kannel  WB, Heslin  AS, Kahn  HA.  Cigarette smoking and coronary heart disease: combined experience of the Albany and Framingham studies.  N Engl J Med. 1962;266:796-801. doi:10.1056/NEJM196204192661602PubMedGoogle ScholarCrossref
5.
Fenelon  A, Preston  SH.  Estimating smoking-attributable mortality in the United States.  Demography. 2012;49(3):797-818. doi:10.1007/s13524-012-0108-xPubMedGoogle ScholarCrossref
6.
Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Rockville, MD: Dept of Health and Human Services; 2014:1081.
7.
Department of Health and Human Services. The Health Consequences of Smoking: Cardiovascular Disease: A Report of the Surgeon General. Rockville, MD: Dept of Health and Human Services; 1983:385.
8.
Kawachi  I, Colditz  GA, Stampfer  MJ,  et al.  Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women.  Arch Intern Med. 1994;154(2):169-175. doi:10.1001/archinte.1994.00420020075009PubMedGoogle ScholarCrossref
9.
Thun  MJ, Carter  BD, Feskanich  D,  et al.  50-Year trends in smoking-related mortality in the United States.  N Engl J Med. 2013;368(4):351-364. doi:10.1056/NEJMsa1211127PubMedGoogle ScholarCrossref
10.
Rosenberg  L, Kaufman  DW, Helmrich  SP, Shapiro  S.  The risk of myocardial infarction after quitting smoking in men under 55 years of age.  N Engl J Med. 1985;313(24):1511-1514. doi:10.1056/NEJM198512123132404PubMedGoogle ScholarCrossref
11.
Rosenberg  L, Palmer  JR, Shapiro  S.  Decline in the risk of myocardial infarction among women who stop smoking.  N Engl J Med. 1990;322(4):213-217. doi:10.1056/NEJM199001253220401PubMedGoogle ScholarCrossref
12.
Cook  DG, Shaper  AG, Pocock  SJ, Kussick  SJ.  Giving up smoking and the risk of heart attacks: a report from the British Regional Heart Study.  Lancet. 1986;2(8520):1376-1380. doi:10.1016/S0140-6736(86)92017-9PubMedGoogle ScholarCrossref
13.
D’Agostino  RB  Sr, Vasan  RS, Pencina  MJ,  et al.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.  Circulation. 2008;117(6):743-753. doi:10.1161/CIRCULATIONAHA.107.699579PubMedGoogle ScholarCrossref
14.
Lloyd-Jones  DM, Huffman  MD, Karmali  KN,  et al.  Estimating longitudinal risks and benefits from cardiovascular preventive therapies among medicare patients: the Million Hearts longitudinal ASCVD risk assessment tool: a special report from the American Heart Association and American College of Cardiology.  Circulation. 2017;135(13):e793-e813. doi:10.1161/CIR.0000000000000467PubMedGoogle ScholarCrossref
15.
Jamal  A, Phillips  E, Gentzke  AS,  et al.  Current cigarette smoking among adults—United States, 2016.  MMWR Morb Mortal Wkly Rep. 2018;67(2):53-59. doi:10.15585/mmwr.mm6702a1PubMedGoogle ScholarCrossref
16.
Tindle  HA, Stevenson Duncan  M, Greevy  RA,  et al.  Lifetime smoking history and risk of lung cancer: results from the Framingham Heart Study.  J Natl Cancer Inst. 2018;110(11):1201-1207. doi:10.1093/jnci/djy041PubMedGoogle Scholar
17.
Doyle  JT, Dawber  TR, Kannel  WB, Kinch  SH, Kahn  HA.  The relationship of cigarette smoking to coronary heart disease: the second report of the combined experience of the Albany, NY and Framingham, Mass studies.  JAMA. 1964;190:886-890. doi:10.1001/jama.1964.03070230022006PubMedGoogle Scholar
18.
Lloyd-Jones  DM, Martin  DO, Larson  MG, Levy  D.  Accuracy of death certificates for coding coronary heart disease as the cause of death.  Ann Intern Med. 1998;129(12):1020-1026. doi:10.7326/0003-4819-129-12-199812150-00005PubMedGoogle ScholarCrossref
19.
Fox  CS, Evans  JC, Larson  MG,  et al.  A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death.  Am J Cardiol. 2005;95(7):856-859. doi:10.1016/j.amjcard.2004.12.011PubMedGoogle ScholarCrossref
20.
Ronksley  PE, Brien  SE, Turner  BJ, Mukamal  KJ, Ghali  WA.  Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis.  BMJ. 2011;342(7795):d671. doi:10.1136/bmj.d671PubMedGoogle ScholarCrossref
21.
Lavie  CJ, Milani  RV, Ventura  HO.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.  J Am Coll Cardiol. 2009;53(21):1925-1932. doi:10.1016/j.jacc.2008.12.068PubMedGoogle ScholarCrossref
22.
Clair  C, Rigotti  NA, Porneala  B,  et al.  Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes.  JAMA. 2013;309(10):1014-1021. doi:10.1001/jama.2013.1644PubMedGoogle ScholarCrossref
23.
Little  RJA.  Missing-data adjustments in large surveys.  J Bus Econ Stat. 1988;6(3):287-296. doi:10.2307/1391878Google Scholar
24.
Schafer  J.  Analysis of Incomplete Multivariate Data. New York, NY: Chapman & Hall; 1997. doi:10.1201/9781439821862
25.
Harrell  F.  Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. 2nd ed. New York, NY: Springer; 2015.
26.
Doll  R, Peto  R, Boreham  J, Sutherland  I.  Mortality from cancer in relation to smoking: 50 years observations on British doctors.  Br J Cancer. 2005;92(3):426-429. doi:10.1038/sj.bjc.6602359PubMedGoogle ScholarCrossref
27.
Ahmed  AA, Patel  K, Nyaku  MA,  et al.  Risk of heart failure and death after prolonged smoking cessation: role of amount and duration of prior smoking.  Circ Heart Fail. 2015;8(4):694-701. doi:10.1161/CIRCHEARTFAILURE.114.001885PubMedGoogle ScholarCrossref
28.
Kawachi  I, Colditz  GA, Stampfer  MJ,  et al.  Smoking cessation in relation to total mortality rates in women: a prospective cohort study.  Ann Intern Med. 1993;119(10):992-1000. doi:10.7326/0003-4819-119-10-199311150-00005PubMedGoogle ScholarCrossref
29.
Kawachi  I, Colditz  GA, Stampfer  MJ,  et al.  Smoking cessation and decreased risk of stroke in women.  JAMA. 1993;269(2):232-236. doi:10.1001/jama.1993.03500020066033PubMedGoogle ScholarCrossref
30.
Amin  NP, Martin  SS, Blaha  MJ, Nasir  K, Blumenthal  RS, Michos  ED.  Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.  J Am Coll Cardiol. 2014;63(25 pt A):2789-2794. doi:10.1016/j.jacc.2014.04.010PubMedGoogle ScholarCrossref
31.
Rana  JS, Tabada  GH, Solomon  MD,  et al.  Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population.  J Am Coll Cardiol. 2016;67(18):2118-2130. doi:10.1016/j.jacc.2016.02.055PubMedGoogle ScholarCrossref
32.
Muntner  P, Colantonio  LD, Cushman  M,  et al.  Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.  JAMA. 2014;311(14):1406-1415. doi:10.1001/jama.2014.2630PubMedGoogle ScholarCrossref
33.
National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).  Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.  Circulation. 2002;106(25):3143-3421. doi:10.1161/circ.106.25.3143PubMedGoogle ScholarCrossref
34.
Ridker  PM, Buring  JE, Rifai  N, Cook  NR.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.  JAMA. 2007;297(6):611-619. doi:10.1001/jama.297.6.611PubMedGoogle ScholarCrossref
35.
Wilson  PW, D’Agostino  RB, Levy  D, Belanger  AM, Silbershatz  H, Kannel  WB.  Prediction of coronary heart disease using risk factor categories.  Circulation. 1998;97(18):1837-1847. doi:10.1161/01.CIR.97.18.1837PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right

Name Your Search

Save Search
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Topics
State Requirements